BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2583 related articles for article (PubMed ID: 8077469)

  • 1. Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician.
    Lawson DD; Moore DH; Schneider JS; Sagebiel RW
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):438-44. PubMed ID: 8077469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of nevus count with prevention attitudes and behaviors before melanoma diagnosis.
    Mayer JE; Swetter SM; Miller DR; Sober AJ; Johnson TM; Geller AC
    Melanoma Res; 2016 Oct; 26(5):513-6. PubMed ID: 27387129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination.
    Buettner PG; Garbe C
    Am J Epidemiol; 2000 Jan; 151(1):72-7. PubMed ID: 10625176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of self-examination for cutaneous malignant melanoma risk factors.
    Gruber SB; Roush GC; Barnhill RL
    Am J Prev Med; 1993; 9(1):50-4. PubMed ID: 8439439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.
    Geller AC; Mayer JE; Sober AJ; Miller DR; Argenziano G; Johnson TM; Swetter SM
    JAMA Dermatol; 2016 Apr; 152(4):413-8. PubMed ID: 26934430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Assessment Questionnaire on Patient-Physician Concordance on Nevus Self-Count and Models Development to Predict High-Risk Phenotype >50 Nevi.
    Mannino M; Sollena P; Esposito M; Fargnoli MC; Peris K; Nagore E
    Dermatology; 2022; 238(5):986-995. PubMed ID: 35462375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient perspectives of early detection of melanoma: the experience at the Brescia Melanoma Centre, Italy.
    Manganoni AM; Pavoni L; Calzavara-Pinton P
    G Ital Dermatol Venereol; 2015 Apr; 150(2):149-54. PubMed ID: 24825405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma risk factors and atypical moles.
    Williams ML; Sagebiel RW
    West J Med; 1994 Apr; 160(4):343-50. PubMed ID: 8023484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma and nevi: detection and diagnosis.
    Choi JN; Hanlon A; Leffell D
    Curr Probl Cancer; 2011; 35(4):138-61. PubMed ID: 21911179
    [No Abstract]   [Full Text] [Related]  

  • 11. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry.
    Rieger E; Soyer HP; Garbe C; Büttner P; Kofler R; Weiss J; Stocker U; Krüger S; Roser M; Weckbecker J
    Int J Cancer; 1995 Aug; 62(4):393-7. PubMed ID: 7635564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rare melanocytes and nevus-cell nevi].
    Frenk E; Mevorah B; Delacrétaz J
    Hautarzt; 1975 Dec; 26(12):619-24. PubMed ID: 1213881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles.
    Bataille V; Snieder H; MacGregor AJ; Sasieni P; Spector TD
    J Natl Cancer Inst; 2000 Mar; 92(6):457-63. PubMed ID: 10716963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accuracy of skin self-examination for atypical nevi.
    Titus-Ernstoff L; Thörn M; Tosteson TD; Brahme EM; Yuen J; Baron JA; Adami HO
    Epidemiology; 1996 Nov; 7(6):619-23. PubMed ID: 8899388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for early melanoma detection: Approaches to the patient with nevi.
    Goodson AG; Grossman D
    J Am Acad Dermatol; 2009 May; 60(5):719-35; quiz 736-8. PubMed ID: 19389517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
    Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
    Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevi and Breslow thickness in melanoma: sex differences?
    De Giorgi V; Scarfì F; Gori A; Maida P; Trane L; Silvestri F; Portelli F; Massi D; Covarelli P; Gandini S
    Melanoma Res; 2020 Apr; 30(2):179-184. PubMed ID: 31574530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear and cytoplasmic features in the diagnosis of Clark's nevi.
    Valdebran M; Bandino J; Elbendary A; Gad A; Arudra KC; de Feraudy S; Elston DM
    J Cutan Pathol; 2018 Mar; 45(3):204-207. PubMed ID: 29193203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermoscopic features of common nevi: a review.
    Kim JK; Nelson KC
    G Ital Dermatol Venereol; 2012 Apr; 147(2):141-8. PubMed ID: 22481577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 130.